CINECA IRIS Institutional Research Information System

BOCCHIO CHIAVETTO, LUISELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.357
EU - Europa 6.654
AS - Asia 1.496
AF - Africa 252
SA - Sud America 71
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 3
Totale 16.855
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.227
RU - Federazione Russa 3.378
DE - Germania 1.495
CN - Cina 727
UA - Ucraina 608
SG - Singapore 581
SE - Svezia 285
GB - Regno Unito 244
CM - Camerun 236
FR - Francia 155
IT - Italia 146
FI - Finlandia 132
CA - Canada 122
IE - Irlanda 94
TR - Turchia 87
PL - Polonia 84
BR - Brasile 56
IN - India 28
EU - Europa 22
VN - Vietnam 12
HK - Hong Kong 10
ES - Italia 8
IL - Israele 8
MX - Messico 7
IR - Iran 5
MA - Marocco 5
PE - Perù 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
BD - Bangladesh 4
HU - Ungheria 4
ID - Indonesia 4
JP - Giappone 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
AT - Austria 3
BE - Belgio 3
LT - Lituania 3
AM - Armenia 2
AU - Australia 2
BO - Bolivia 2
DZ - Algeria 2
EC - Ecuador 2
JO - Giordania 2
KZ - Kazakistan 2
MY - Malesia 2
NL - Olanda 2
PK - Pakistan 2
RO - Romania 2
AZ - Azerbaigian 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
IQ - Iraq 1
KE - Kenya 1
KR - Corea 1
LY - Libia 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
PY - Paraguay 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 16.855
Salva come PNG Salva come JPEG
Città #
Fairfield 1.564
Woodbridge 699
Seattle 695
Ashburn 694
Houston 661
Beijing 636
Cambridge 604
Jacksonville 560
Chandler 539
Wilmington 504
Moscow 304
Ann Arbor 213
Singapore 184
The Dalles 110
Ottawa 106
Boardman 103
Chicago 95
Dublin 91
Lawrence 90
Princeton 86
New York 74
Kraków 65
Helsinki 64
Rome 61
London 51
San Diego 49
Saint Petersburg 35
Frankfurt am Main 31
Los Angeles 31
Portsmouth 28
Yubileyny 25
Lauterbourg 19
Nanjing 17
Norwalk 16
Prescot 16
Cedar Knolls 13
Kunming 13
Redwood City 13
San Francisco 13
Chiswick 12
Guangzhou 12
Warsaw 11
Düsseldorf 10
Milan 10
Mumbai 10
Hefei 9
Hong Kong 9
Islington 9
Kilburn 9
Roubaix 9
Atlanta 8
Dearborn 8
Hounslow 8
Falls Church 7
Mcallen 7
Wroclaw 7
Mexico City 6
Boston 5
Brooklyn 5
Chengdu 5
Johannesburg 5
Nanchang 5
Redmond 5
St Louis 5
Stockholm 5
São Paulo 5
Bexley 4
Dallas 4
Hanoi 4
New Bedfont 4
Shanghai 4
Toronto 4
West Jordan 4
Ankara 3
Brussels 3
Chennai 3
Council Bluffs 3
Guarulhos 3
Ho Chi Minh City 3
Istanbul 3
Jinan 3
Kocaeli 3
Munich 3
Porto Alegre 3
Rimini 3
Riyadh 3
Santa Clara 3
Segrate 3
Shenyang 3
Sotto 3
The Bronx 3
Tokyo 3
Almaty 2
Assago 2
Barcelona 2
Behshahr 2
Caruaru 2
Charlotte 2
Columbus 2
Garden City 2
Totale 9.479
Salva come PNG Salva come JPEG
Nome #
The -1727 A/T, -50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms and resistance to antipsychotics in schizophrenia 437
Immune and metabolic alterations in first episode psychosis (FEP) patients 369
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 321
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 281
Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients 280
Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis 279
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects 277
Allelic variation in the human prodynorphin gene promoter and schizophrenia 259
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients 251
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. 248
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 245
Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease 245
Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease 245
Aspetti biologici e neuropsicologici del maltrattamento e abuso infantili 242
Effetti biomolecolari del maltrattamento infantile: il ruolo dell'epigenetica e dell'infiammazione 242
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 239
Serum levels of brain-derived neurotrophic factor in drug-naive obsessive-compulsive patients: A case-control study 235
BDNF Val66Met polymorphism and protein levels in Amniotic Fluid 233
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses 228
Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients 228
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 228
Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia 222
Glucose metabolism alterations in patients with bipolar disorder 222
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence 222
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study 221
Haptoglobin polymorphism and schizophrenia: Genetic variation on chromosome 16 218
Nanomedicine in Psychiatry: New Therapeutic Opportunities from Research on Small RNAs 218
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients 218
Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults. 217
Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia 215
Serum Levels of Insulin-Like Growth Factor-1 and Obsessive-Compulsive Disorder: A Case-Control Study 215
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 214
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 214
Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor 208
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 208
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 208
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease 205
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment 205
Blood microRNA changes in depressed patients during antidepressant treatment 204
Season of birth and inflammatory response system in schizophrenia 203
Markers of Alzheimer's disease in a population attending a memory clinic 202
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial 202
Blood microRNA longitudinal changes in depressed patients during antidepressant treatment 201
Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients 201
Influence of serotonin receptor 2A His452Tyr polymorphism on brain temporal structures: a volumetric MR study 200
Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter 195
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 195
Effects of Intranasal Oxytocin on Long-Term Memory in Healthy Humans: A Systematic Review 194
G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 194
Lack of association between MnSOD gene polymorphism and sporadic Alzheimer's disease 192
VEGF serum levels in depressed patients during SSRI antidepressant treatment 192
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 191
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 189
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers 187
Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics 187
Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases 186
Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum. 183
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 182
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 178
No occurrence of the glutamate transporter EAAT2 A206G polymorphism in schizophrenic subjects 170
Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants 161
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis 156
Association study of-1727 A/T,-50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms with schizophrenia 150
Association study and meta-analysis of-308 A/G functional polymorphism in TNF alpha gene with schizophrenia 147
Association between IL-1 cluster and IL-10 gene polymorphisms and schizophrenia 147
Gene-environment interaction in major depression: focus on experience-dependent biological systems 147
Association between IL-1 beta-511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia 147
CYP2D6 polymorphism in patients with Alzheimer's disease in treatment with cholinesterase inhibitors 144
Association study between -1727A/T, -50C/T and (CAA)(N) repeat GSK-3beta gene polymorphisms and Bipolar Disorder 143
The cytokine network genes and resistance to antipsychotics in schizophrenia 137
Influence of G1730A polymorphism of estrogen receptor beta gene on brain morphology in postmenopausal women 135
Peripheral BDNF levels and personality traits in a sample of subjects non affected by psychiatric diseases 132
Evidence in Support of the AD Biomarker Dynamic Model from a Memory Clinic Naturalistic Series of Patients with Mild Cognitive Impairment 132
Serum brain derived neurotrophic factor concentrations in attention deficit hyperactivity disorder (ADHD) 128
Brain-derived neurotrophic factor as potential diagnostic biochemical marker of depressive state 127
Childhood trauma and glucose metabolism in patients with first-episode psychosis 127
Serum and plasma BDNF levels in major depression: Replication study plus meta-analysis 125
miR-146a Plasma Levels Are Not Altered in Alzheimer's Disease but Correlate With Age and Illness Severity 117
Myeloid microvesicles in CSF are associated with myelin damage and neuronal loss in mild cognitive impairment and alzheimer disease. 114
Plasma Aβ42 as Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study 113
Molecular mechanisms of brain stimulation. (Chapter 11). 108
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response 100
Alterations observed in the interferon α and β signaling pathway in MDD patients are marginally influenced by cis-acting alleles 96
A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup. 81
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients 78
Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients 64
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations 61
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial) 59
P.264 Association of single nucleotide polymorphisms in the 3’ untranslated region of SLC1A2 with major depressive disorder and relative endophenotypes 55
Vascular endothelial growth factor (VEGF) serum: putative predictive biomarkers for the electroconvulsive therapy (ECT) in depressed patients 43
Reduction of oxytocin plasma levels in borderline personality disorder and normalization induced by psychotherapies 18
Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed Patients 12
Can We Modulate Our Second Brain and Its Metabolites to Change Our Mood? A Systematic Review on Efficacy, Mechanisms, and Future Directions of "Psychobiotics" 11
null 5
null 2
null 1
null 1
null 1
Totale 17.015
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.244
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.244
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.492 0 294 248 400 288 243 322 142 125 116 247 67
2021/2022598 108 59 128 46 9 21 21 139 33 23 8 3
2022/20231.614 176 11 11 221 167 344 1 230 299 43 87 24
2023/2024558 27 40 62 68 59 86 21 10 0 16 5 164
2024/20254.245 34 22 18 3 113 319 2.282 779 302 62 183 128
2025/2026189 181 8 0 0 0 0 0 0 0 0 0 0
Totale 17.015